Aryan Malhotra, Aarti K Jain, Eric Feldstein, Eilene Basu, Ariel Sacknovitz, Shayna Kar, Isaac B Thorman, Sauson Soldozy, James M Beck, Nimrod Gozum, Gurmeen Kaur, Chirag D Gandhi, Fawaz Al-Mufti
{"title":"Outcomes of acute ischemic stroke and reperfusion therapy in patients with Moyamoya disease.","authors":"Aryan Malhotra, Aarti K Jain, Eric Feldstein, Eilene Basu, Ariel Sacknovitz, Shayna Kar, Isaac B Thorman, Sauson Soldozy, James M Beck, Nimrod Gozum, Gurmeen Kaur, Chirag D Gandhi, Fawaz Al-Mufti","doi":"10.1080/01616412.2026.2755880","DOIUrl":"https://doi.org/10.1080/01616412.2026.2755880","url":null,"abstract":"<p><strong>Objectives: </strong>Moyamoya disease (MMD) is an uncommon cerebrovascular condition associated with acute ischemic stroke (AIS) and intracranial hemorrhage. This study examines outcomes of AIS in patients with MMD (MMD-AIS) and associated outcomes of endovascular thrombectomy (EVT) and intravascular thrombolysis (IVT).</p><p><strong>Methods: </strong>This retrospective cross-sectional analysis used the National Inpatient Sample database (2015-2022), including adult (≥18 years-old) U.S. hospitalizations for AIS with reported NIH Stroke Scale (NIHSS). Inverse probability of treatment weighting adjusted for confounding factors. Multivariable logistic regression estimated adjusted odds ratios (aORs) and 95% confidence intervals (CIs).</p><p><strong>Results: </strong>Among 1,733,390 AIS hospitalizations, 3,735 (0.2%) involved comorbid MMD; 150 (4.0%) underwent EVT while 300 (8.0%) received IVT. MMD was associated with reduced use of EVT (aOR: 0.362, 95% CI [0.238-0.553], <i>p</i> < 0.001) and IVT (0.315 [0.242-0.412], <i>p</i> < 0.001) compared with non-MMD AIS. Following IPTW, MMD was associated with similar inpatient mortality (1.29 [0.797-2.09], <i>p</i> = 0.299), reduced routine discharge (0.639 [0.540-0.757], <i>p</i> < 0.001), and similar hemorrhagic transformation (1.13 [0.742-1.74], <i>p</i> = 0.560). Among the MMD-AIS group with NIHSS > 5, EVT was not associated with differences in routine discharge (0.672 [0.398-1.14], <i>p</i> = 0.137), inpatient mortality (0.072 [0.004-1.20], <i>p</i> = 0.067), or hemorrhagic transformation (1.61 [0.896-2.88], <i>p</i> = 0.111). IVT was associated with increased routine discharge (1.96 [1.35-2.85], <i>p</i> < 0.001), and no difference in hemorrhagic transformation (0.948 [0.542-1.66], <i>p</i> = 0.852) or mortality (1.74 [0.811-3.75], <i>p</i> = 0.155).</p><p><strong>Discussion: </strong>MMD-AIS was associated with reduced routine discharge without increased hemorrhagic risk. EVT and IVT were infrequently used but may be feasible in selected patients. Prospective studies are needed to determine the efficacy of reperfusion therapy in this population.</p>","PeriodicalId":19131,"journal":{"name":"Neurological Research","volume":" ","pages":"1-10"},"PeriodicalIF":1.9,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149408867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Brain arteriovenous malformations: state of the art, evolving risk stratification, and emerging molecular therapies.","authors":"Denise Brunozzi, Ali Alaraj","doi":"10.1080/01616412.2026.2755875","DOIUrl":"https://doi.org/10.1080/01616412.2026.2755875","url":null,"abstract":"","PeriodicalId":19131,"journal":{"name":"Neurological Research","volume":" ","pages":"1-4"},"PeriodicalIF":1.9,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149408866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Qian Dong, Xiao Hu, Zijie Wang, Jiaxin Luo, Zizhen Meng, Min Liu, Juan Li, Guiyou Li, Zaichao Liu, Rui Cheng, Qi Li
{"title":"Comparison of agreement between semi-automated software and the ABC/2 method in quantifying hematoma and perihematomal edema volumes in intracerebral hemorrhage.","authors":"Qian Dong, Xiao Hu, Zijie Wang, Jiaxin Luo, Zizhen Meng, Min Liu, Juan Li, Guiyou Li, Zaichao Liu, Rui Cheng, Qi Li","doi":"10.1080/01616412.2026.2762289","DOIUrl":"https://doi.org/10.1080/01616412.2026.2762289","url":null,"abstract":"<p><strong>Background: </strong>Reliable quantification of intracerebral hemorrhage (ICH) and perihematomal edema (PHE) is essential for clinical research, yet inter-method agreement remains unclear. We compared agreement for ICH and PHE volumes among three semi-automated software platforms as well as between ABC/2 and the software-derived average, assessing the effects of hematoma morphology and ICH volume.</p><p><strong>Methods: </strong>We analyzed 153 ICH patients who underwent non-contrast CT within 24 hours. ICH and PHE volumes were measured using ABC/2 and three platforms (3D Slicer, Analyze, ITK-SNAP). The software-derived average served as a composite comparator for ABC/2. Agreement was assessed using intraclass correlation coefficients (ICCs) and Bland-Altman analysis. Proportional bias was assessed by regression. Subgroups included hematoma morphology and ICH volume.</p><p><strong>Results: </strong>Across pairwise comparisons, the three platforms showed excellent ICH agreement (ICCs >0.99; 95% limits of agreement (LOA): -3.65 to 2.39 mL). For PHE, despite excellent ICCs (>0.90), the 95% LOA were wider (-5.98 to 6.39 mL). Compared with the software-derived average, ABC/2 yielded higher ICH (+4.15 mL) and PHE (+0.96 mL) volumes, with significant proportional bias (<i>p</i> < 0.001). For ICH, ABC/2 bias was greater in irregular (7.50 vs 2.06 mL) and larger (10.25 vs 1.92 mL) hematomas, whereas PHE bias did not differ significantly across subgroups.</p><p><strong>Conclusions: </strong>The three software platforms showed excellent agreement for ICH volume, whereas PHE measurements should be interpreted cautiously because of the wide LOA. ABC/2 yielded higher volumes than the software-derived average, particularly in irregular and larger hematomas, which may affect classification near trial eligibility thresholds.</p>","PeriodicalId":19131,"journal":{"name":"Neurological Research","volume":" ","pages":"1-12"},"PeriodicalIF":1.9,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hosam Al-Jehani, Hayder M Al-Kuraishy, Duaa Eliwa, Gaber El-Saber Batiha
{"title":"Platelets in Alzheimer's disease: pathogenic mechanisms and therapeutic implications.","authors":"Hosam Al-Jehani, Hayder M Al-Kuraishy, Duaa Eliwa, Gaber El-Saber Batiha","doi":"10.1080/01616412.2026.2762288","DOIUrl":"https://doi.org/10.1080/01616412.2026.2762288","url":null,"abstract":"<p><strong>Objectives: </strong>This review examines the role of platelets, the primary peripheral source of amyloid precursor protein (APP) and amyloid-beta (Aβ), in Alzheimer's disease (AD) pathogenesis, focusing on the bidirectional feedback loop between peripheral platelet over-activation and central neuropathology, alongside potential antiplatelet therapies.</p><p><strong>Methods: </strong>A narrative review was conducted evaluating literature on platelet biological functions, pathological shifts in platelet APP processing in AD, mechanisms of blood-brain barrier (BBB) breakdown, and the therapeutic potential of antiplatelet agents (e.g. aspirin, clopidogrel) and adenosine A<sub>2A</sub> receptor modulators.</p><p><strong>Results: </strong>In AD patients, platelet APP expression is markedly upregulated, shifting toward amyloidogenic processing via decreased α-secretase and increased β-secretase activity. Activated platelets breach the BBB, release pro-inflammatory mediators into the brain parenchyma, and promote cerebral Aβ deposition. Reciprocally, central AD pathology further drives systemic platelet activation, creating a self-reinforcing disease loop.</p><p><strong>Conclusions: </strong>A clear, bidirectional relationship may exist between activated platelets and AD neuropathology. Because peripheral platelets actively fuel central amyloid accumulation and neuroinflammation, targeting platelet activation may be a viable strategy to mitigate AD risk and slow disease progression.</p>","PeriodicalId":19131,"journal":{"name":"Neurological Research","volume":" ","pages":"1-19"},"PeriodicalIF":1.9,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Posterior cerebral artery dissection: clinical and angiographic spectrum, management, and outcomes in a retrospective 14-patient case series.","authors":"Zehra Uysal Kocabaş, Zakir Erat, Emre Özkara, Özlem Aykaç, Atilla Ozcan Özdemir","doi":"10.1080/01616412.2026.2752406","DOIUrl":"https://doi.org/10.1080/01616412.2026.2752406","url":null,"abstract":"<p><strong>Background: </strong>Posterior cerebral artery (PCA) dissection is a rare cerebrovascular disorder with heterogeneous clinical and angiographic presentations. Because evidence is largely limited to small case series and individual reports, optimal diagnostic and therapeutic strategies remain uncertain.</p><p><strong>Methods: </strong>We retrospectively reviewed 14 patients with angiographically confirmed PCA dissection or dissecting PCA aneurysms identified at a single center between January 2016 and December 2025. Clinical presentation, angiographic characteristics, treatment strategy, procedural complications, and available clinical and vascular imaging follow-up were analyzed.</p><p><strong>Results: </strong>The median age was 43.5 years (IQR, 33.8-56.3; range, 20-63 years). Hemorrhagic presentation occurred in 8 patients (57.1%), including 6 with subarachnoid hemorrhage (42.9%). Two patients were managed conservatively, 3 underwent conventional stenting alone, 5 underwent flow-diverter treatment, 2 underwent coil embolization without an implanted stent, and 2 underwent conventional stenting combined with coil embolization. Most patients achieved favorable clinical and angiographic outcomes. One patient remained severely disabled (mRS 5), and one patient developed fatal post-procedural subarachnoid hemorrhage after flow-diverter treatment.</p><p><strong>Conclusions: </strong>PCA dissection is a rare and clinically heterogeneous condition that may present with hemorrhagic or nonhemorrhagic manifestations. Management should be individualized according to rupture status, lesion morphology, vascular anatomy, collateral circulation, and the feasibility of parent-vessel preservation. Conservative management and different endovascular strategies may be appropriate in selected patients, but the small retrospective nature of available series precludes conclusions regarding superiority of any single treatment approach.</p>","PeriodicalId":19131,"journal":{"name":"Neurological Research","volume":" ","pages":"1-10"},"PeriodicalIF":1.9,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lichao Li, Yan Cheng, Huaning Tian, Xiaoyu Bai, Long Zhang, Maohua Zheng
{"title":"Association of decreased serum Netrin-1 with inflammatory markers, neurological severity, and 3-month outcome in hypertensive intracerebral hemorrhage.","authors":"Lichao Li, Yan Cheng, Huaning Tian, Xiaoyu Bai, Long Zhang, Maohua Zheng","doi":"10.1080/01616412.2026.2755872","DOIUrl":"https://doi.org/10.1080/01616412.2026.2755872","url":null,"abstract":"<p><strong>Objective: </strong>To compare serum Netrin-1 levels among hypertensive intracerebral hemorrhage (HICH) patients, hypertensive patients without cerebrovascular lesions and healthy controls, and analyze its correlations with inflammatory markers, neurological deficit severity and 3-month functional prognosis.</p><p><strong>Methods: </strong>This single-center retrospective cohort enrolled 294 participants from September 2021 to September 2022, including 98 HICH patients, 92 uncomplicated primary hypertension patients and 104 healthy subjects. Serum samples were collected within routine clinical time windows, yet the intervals from hemorrhage onset and acute treatments to blood collection were inconsistent. Multiple subgroup, correlation and prognostic analyses were conducted with exact <i>p</i>-values presented; <i>p</i> < 0.01 was set as a strict threshold for primary interpretations.</p><p><strong>Results: </strong>HICH patients had markedly lower serum Netrin-1 than healthy controls (<i>p</i> < 0.001), with no significant difference versus hypertensive patients (<i>p</i> = 0.083). Netrin-1 was negatively correlated with NIHSS, mRS, IL-6 and CRP, and positively correlated with IL-10. Its concentrations declined progressively with aggravated neurological impairment. Multivariate regression identified low Netrin-1, high NIHSS and brainstem hemorrhage as independent predictors of poor 3-month outcome (GOS 1-3). The internal ROC analysis showed an AUC of 0.896 (95%CI 0.817-0.923).</p><p><strong>Conclusion: </strong>Reduced serum Netrin-1 correlates with severe neurological damage and unfavorable 3-month prognosis in HICH, serving as an independent prognostic indicator after covariate adjustment. Restricted by retrospective single-center design, inconsistent sampling timing, insufficient outcome events and lack of external validation, Netrin-1 is merely an investigational biomarker rather than a validated clinical prognostic assay.</p>","PeriodicalId":19131,"journal":{"name":"Neurological Research","volume":" ","pages":"1-12"},"PeriodicalIF":1.9,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149342966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Eduardo Ichikawa-Escamilla, Eric M Estrada-Estrada, Teodulo D Valenzuela-Hernández, Félix Domínguez-Cortinas, Víctor Correa-Correa, Andrea García-Bitar, Fernando D Benavides-Gómez, Diego Molina-Botello, Edgar F Higuera-González, Julio César López-Valdés, Blas E López-Félix
{"title":"Exoscope-assisted resection of spinal tumors: volumetric efficacy, safety and learning curve analysis in 47 consecutive cases.","authors":"Eduardo Ichikawa-Escamilla, Eric M Estrada-Estrada, Teodulo D Valenzuela-Hernández, Félix Domínguez-Cortinas, Víctor Correa-Correa, Andrea García-Bitar, Fernando D Benavides-Gómez, Diego Molina-Botello, Edgar F Higuera-González, Julio César López-Valdés, Blas E López-Félix","doi":"10.1080/01616412.2026.2755505","DOIUrl":"https://doi.org/10.1080/01616412.2026.2755505","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the clinical outcomes, volumetric extent of resection, safety profile, and skill acquisition dynamics of 3D-4K digital exoscope-assisted spinal tumor resection.</p><p><strong>Methods: </strong>A retrospective analytical single-center study was conducted on 47 consecutive patients undergoing exoscope-assisted resection across intramedullary (IM, <i>n</i> = 7), intradural extramedullary (IDEM, <i>n</i> = 34), and extradural (ED, <i>n</i> = 6) compartments. Extent of resection was determined via blinded postoperative subtraction MRI. Surgical skill acquisition was modeled using sequential Cumulative Sum (CUSUM) analysis of intraoperative blood loss.</p><p><strong>Results: </strong>Mean age was 49.1 ± 17.3 years (63.8% female). Overall Gross Total Resection (GTR > 95%) was achieved in 85.1% (<i>n</i> = 40/47), reaching 100% in IM lesions (<i>n</i> = 7/7) and 82.4% in IDEM tumors (<i>n</i> = 28/34, <i>p</i> = 0.567). Postoperative CSF fistula occurred in 6.4% (<i>n</i> = 3/47), restricted exclusively to IDEM Schwannomas. Median operative time was 3.27 hours (IQR: 2.68-5.05; <i>n</i> = 32/47). Median hospital stay was 3.0 days (IQR: 3.0-5.0). At 6-month follow-up, paired evaluations demonstrated significant functional and pain improvements (mMs and ODI/NDI, <i>p</i> < 0.001). Sequential CUSUM analysis identified a structural break at case 28, marking the transition to technical mastery without blood loss inflation during early cases (<i>p</i> = 0.553).</p><p><strong>Conclusions: </strong>Resection of spinal tumors using the 3D-4K exoscope is safe, effective, and yields high volumetric resection rates. Skill acquisition follows a patient-safe learning curve, achieving technical proficiency at case 28.</p>","PeriodicalId":19131,"journal":{"name":"Neurological Research","volume":" ","pages":"1-12"},"PeriodicalIF":1.9,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149334702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"State-specific alterations in dynamic functional network connectivity in Wilson's disease: a resting-state fMRI study.","authors":"Xianchao Yu, Hongfei Xia, Siqi Zhuang, Hui Tang, Yinghong Zhao","doi":"10.1080/01616412.2026.2755874","DOIUrl":"https://doi.org/10.1080/01616412.2026.2755874","url":null,"abstract":"<p><strong>Background: </strong>Dynamic functional network connectivity (dFNC) may reveal time-varying brain network abnormalities in Wilson's disease (WD) that are not captured by static analyses. We aimed to characterize static and dynamic large-scale network connectivity in WD using resting-state fMRI.</p><p><strong>Methods: </strong>This retrospective study included 32 patients with WD and 32 healthy controls. Group independent component analysis identified eight components representing seven resting-state networks. Static connectivity was assessed across the full scan, while dynamic states were identified using sliding-window correlation and k-means clustering. State-specific connectivity and temporal metrics were compared between groups, and clinical associations were explored using Spearman correlation analyses.</p><p><strong>Results: </strong>No sFNC difference survived false discovery rate correction. dFNC revealed group differences in States 2 and 4. In State 2, patients with WD showed increased default mode network (DMN)-left frontoparietal network connectivity and decreased DMN-dorsal attention network (DAN) and DMN-sensorimotor network connectivity. In State 4, DMN-left frontoparietal network and DAN-visual network connectivity increased, whereas DAN-right frontoparietal network connectivity decreased. Patients with WD also had shorter MDT in State 2, which correlated positively with blood urea nitrogen levels (Spearman's <i>r</i> = 0.478, FDR-corrected <i>p</i> = 0.035).</p><p><strong>Conclusion: </strong>WD showed state-specific changes in dynamic brain network connectivity that were not detected by static analysis. The correlation between State 2 MDT and blood urea nitrogen may reflect a relationship between brain network dynamics and peripheral metabolic status.</p>","PeriodicalId":19131,"journal":{"name":"Neurological Research","volume":" ","pages":"1-14"},"PeriodicalIF":1.9,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149323249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Adnan I Qureshi, Kamran Zahoor, Muhammad Shah Miran, Moeez Ahmed, Hassan Naqvi, Jon Manzer, Abdullah Arshad, M Fareed K Suri
{"title":"One-year incidence of newly diagnosed dementia after inpatient sepsis hospitalization.","authors":"Adnan I Qureshi, Kamran Zahoor, Muhammad Shah Miran, Moeez Ahmed, Hassan Naqvi, Jon Manzer, Abdullah Arshad, M Fareed K Suri","doi":"10.1080/01616412.2026.2741665","DOIUrl":"https://doi.org/10.1080/01616412.2026.2741665","url":null,"abstract":"<p><strong>Background: </strong>Sepsis survivors face increased long-term cognitive risk, but contemporary U.S. population-level estimates of claims-ascertained dementia remain limited.</p><p><strong>Objective: </strong>To estimate 1-year incidence of newly documented claims-ascertained dementia after sepsis hospitalization and describe variation by age, sex, payer, and sepsis severity.</p><p><strong>Methods: </strong>We conducted a retrospective cohort-study using a nationally representative U.S. claims database with linked medical, pharmacy, and enrollment data from 1 January 2020 through 31 March 2025. Adults aged 18 years or older with an index sepsis hospitalization, no prior dementia diagnosis, and complete 1-year post-discharge claims observability were included. Newly documented dementia was defined using a claims-based algorithm requiring atleast 2 outpatient claims separated by 30 days or atleast 1 inpatient claim. Exact Clopper-Pearson 95% confidence intervals (CIs) were calculated.</p><p><strong>Results: </strong>Among 35,689 sepsis survivors (mean-age, 62.4 years; 51.5% male; 42.5% Medicare; 19.7% with severe sepsis or septic shock), 1,072 received a newly documented dementia diagnosis within 1 year (3.00%; 95% CI, 2.83%-3.19%). Incidence increased from 0.60% among patients aged 18-64 years to 2.83% among those aged 65-74 years and 8.24% among those aged 75 years or older. Median-time to diagnosis was 112 days (interquartile range, 39-223 days). Incidence was similar by sex and higher with severe sepsis (3.62% vs 2.85%). Sensitivity analyses yielded estimates of 2.19%-4.29%.</p><p><strong>Conclusions: </strong>Approximately 3% of insured adult sepsis survivors with complete 1-year claims observability received a new dementia diagnosis within 1-year, with risk concentrated among older adults. Older sepsis survivors may warrant closer cognitive follow-up, though these findings do not establish screening benefit or sepsis-related dementia risk.</p>","PeriodicalId":19131,"journal":{"name":"Neurological Research","volume":" ","pages":"1-9"},"PeriodicalIF":1.9,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149323248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neurological ResearchPub Date : 2026-11-01Epub Date: 2025-10-16DOI: 10.1080/01616412.2025.2572520
Changzhu Wu, Xianwei Wang, Lingling Zhang, Hong Ni, Weijian Chen, Feng Wang, Weijun Hong, Yiqing Jiang, Liujing Chen, En Wang
{"title":"Endovascular treatment beyond 24 hours for large vessel occlusion strokes selected by CT perfusion.","authors":"Changzhu Wu, Xianwei Wang, Lingling Zhang, Hong Ni, Weijian Chen, Feng Wang, Weijun Hong, Yiqing Jiang, Liujing Chen, En Wang","doi":"10.1080/01616412.2025.2572520","DOIUrl":"10.1080/01616412.2025.2572520","url":null,"abstract":"<p><strong>Background: </strong>The role that endovascular treatment (EVT) may play in stroke patients with large vessel occlusion (LVO) who are treated beyond 24 h after onset is unclear. In this study, we aimed to examine the efficacy and safety of EVT beyond 24 h based on uniform CT perfusion criteria in appropriately selected patients.</p><p><strong>Methods: </strong>A retrospective review was performed at a single stroke center between January 2021 and August 2024. We chose patients who received EVT beyond 24 h while a matched group who received EVT within the 6-24 h time window was chosen as a control. Functional independence (modified Rankin scale score ≤2) at 90 days was used as the primary outcome, and symptomatic intracranial hemorrhage (sICH) and mortality were considered safety outcomes.</p><p><strong>Results: </strong>We selected 400 patients treated with EVT within the 6-24 h time window (late window group) and 82 patients treated beyond 24 h (very late window group). A 2:1 matched group was used for comparison. No significant differences in functional independence (very late, 58.5% vs late, 61.6%, OR, 1.14, 95% CI, 0.66-1.95, <i>p</i> = 0.645) at 90 days, safety outcomes of mortality (very late, 7.3% vs late, 9.8%, OR, 0.73, 95% CI, 0.28-1.94, <i>p</i> = 0.786), or sICH (very late, 2 (2.4%) vs late, 5 (3.0%), OR, 0.80, 95% CI, 0.15-4.19, <i>p</i> = 0.527). Patients with a course of neurological deterioration before EVT tend to have a good prognosis (OR = 27.129, 95% CI, 2.559-288.906, <i>p=</i>0.006).</p><p><strong>Conclusions: </strong>Compared with EVT performed within the 6-24 h, EVT beyond 24 h appears to be feasible and safe for acute LVO stroke patients selected by CT perfusion.</p>","PeriodicalId":19131,"journal":{"name":"Neurological Research","volume":" ","pages":"1564-1573"},"PeriodicalIF":1.9,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145302545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}